0.00Open7.00Pre Close0 Volume2 Open Interest73.00Strike Price0.00Turnover192.51%IV3.23%PremiumDec 13, 2024Expiry Date4.50Intrinsic Value100Multiplier0DDays to Expiry2.50Extrinsic Value100Contract SizeAmericanOptions Type0.9873Delta0.0156Gamma17.22Leverage Ratio-0.4365Theta0.0001Rho17.00Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet